Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–6 of 6 stories
The CDC has issued guidance on the emergency use of doxycycline to prevent anthrax exposure. This policy aims to enhance preparedness against potential bioterrorism threats.
The CDC provides guidance on preparing Doxycycline Hyclate for individuals who cannot swallow pills during anthrax emergencies. This protocol aims to ensure accessibility of critical antibiotics in urgent situations.
The CDC emphasizes the importance of prevention strategies for anthrax, both pre- and post-exposure. This initiative aims to enhance public health responses to potential anthrax threats.
The CDC highlights the serious nature of anthrax, a bacterial disease that affects both animals and humans. Awareness of this disease is crucial for public health and safety.
The CDC highlights job-related risks for anthrax exposure and suggests strategies to mitigate these risks. This guidance is crucial for employers and employees in high-risk sectors.
The CDC emphasizes the need for preparedness in the event of an anthrax emergency. This guidance aims to enhance public health readiness against potential bioterrorism threats.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.